Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jun 21,2018
Breast Cancer Epigenetics Study Reveals Potential Drug Targets
Cell lineages that culminate in mammary gland development may also lead to breast cancer. Although these lineages, as well as the stem cells and progenitor cells they comprise, have been subjected to extensive study, the perturbations of these lineages that increase the risk of breast cancer have remained obscure, frustrating the search for chemoprevention drugs.Read more
More
Breast Cancer Epigenetics Study Reveals Potential Drug Targets
Jun 21,2018
Aggressive Brain Cancer Can Be Driven by Tumor Suppressor
AMP-activated protein kinase (AMPK) is involved in regulating cell metabolism and is largely thought to play a suppressive role in cancer. Research by scientists at the Cincinnati Children's Cancer and Blood Diseases Institute has now indicated that the protein may represent a key driver of aggressive brain cancers, including glioblastoma (GBM). Their studies showed thatRead more
More
Aggressive Brain Cancer Can Be Driven by Tumor Suppressor
Jun 20,2018
Microbiome-Lax May Relieve Constipation
So great a need for constipation relief, so few constipation remedies. If only the estimated 4 million Americans who suffer from constipation had more options, particularly since dietary interventions so often fail. Additional options, new research suggests, may finally be on their way, in the form of genetically engineered probiotics. According to researchers at theRead more
More
Microbiome-Lax May Relieve Constipation
Jun 20,2018
Two Vaccines Are Better Than One for Malaria
The tenacity of the malaria parasite has all too often made it intractable to long-term therapeutic intervention. The development of parasite drug resistance is almost an inevitability, causing public health organizations to rethink treatment and prevention strategies. While vaccines would seem the most viable option toward long-term prevention and eradication, individual vaccines developed thus farRead more
More
Jun 19,2018
Optogenetic Hack Advances Synthetic Morphogenesis
A living organism, says the synthetic biologist, is the output generated by a tangle of interconnected subprograms. Naturally, the synthetic biologist wants to disentangle these programs and – to the extent possible – modularize them, so that they may be plucked from their ordinary, living contexts and put to work, harnessed for applications such asRead more
More
Jun 19,2018
Gut Microbes May Contribute to Depression and Anxiety in Obesity
Like everyone, people with type 2 diabetes and obesity suffer from depression and anxiety, but even more so. Work in mice by researchers in the U.S. and Japan now suggests that bacteria in the gut – the microbiome – may contribute to depressive-type behaviors in animals with diet-induced obesity (DIO). The studies, headed by researchersRead more
More
Gut Microbes May Contribute to Depression and Anxiety in Obesity
Jun 18,2018
New Prostate Cancer Subtype Identified, Responsive to Immunotherapy
Researchers in the U.S. and U.K. have identified a new subtype of prostate cancer that is characterized by loss of both copies of the CDK12 gene, and which an early clinical study showed can respond to immune checkpoint inhibitor drugs that commonly aren't effective against prostate cancer.   The new tumor subtype is characterized byRead more
More
Jun 18,2018
Gene Expression Map Created of Cells in Aging Brain
Researchers say they have mapped the gene expression of each individual brain cell during aging in the fruit fly. Their study ("A Single-Cell Transcriptome Atlas of the Aging Drosophila Brain”), published in Cell, could lead to new insights on the workings of the brain as it ages, according to the scientists. "The diversity of cellRead more
More
Gene Expression Map Created of Cells in Aging Brain
Jun 15,2018
Fast-Acting Vaccine and Probiotic Combat Cholera in Animals
One of the most terrifying things about cholera is its lethal speed. A victim can consume contaminated food or water, come down with diarrhea a day later and, if untreated, be dead a day after that – having inadvertently spread the microorganism to friends, neighbors and family members in the meantime. New probiotic and vaccine-basedRead more
More
Jun 15,2018
Parkinson's Protein Transition Provides Insight into Disease Progression
Researchers say they have completed a detailed brain cell analysis that has helped them to uncover new mechanisms thought to underlie Parkinson's disease. They believe their study ("α-Synuclein Oligomers Interact with ATP Synthase and Open the Permeability Transition Pore in Parkinson's Disease”), published in Nature Communications, adds to the growing understanding of the causes of Parkinson's andRead more
More
Parkinson's Protein Transition Provides Insight into Disease Progression
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->